A positive correlation of serum SFRP1 levels with the risk of developing type 2 diabetes mellitus: a case-control study.

Abstract

Secreted frizzled-related protein 1 (SFRP1) is an adipokine whose production is significantly altered in metabolic disorders. Considering the relationship between dysfunction of Wnt/β-catenin signaling and metabolic disorders as well as the inhibitory effects of SFRP1 on this signaling pathway, the present work aimed to investigate the correlation between serum SFRP1 levels and type 2 diabetes mellitus (T2DM) and its developing risk factors for the first time. This case-control study measured serum levels of SFRP1, tumor necrosis factor (TNF)-α, interleukin (IL)-6, adiponectin, and fasting insulin using enzyme-linked immunosorbent assay kits in 80 T2DM patients and 80 healthy individuals. Biochemical parameters were determined using the AutoAnalyzer instrument. The T2DM group had higher levels of SFRP1 compared with the controls (146.8100±43.61416 vs 81.9531±32.78545 pg/mL; P<.001). There was a positive correlation between SFRP1 and insulin (r=0.327, P=.003), TNF-α (r=0.420, P<.001) as well as homeostatic model assessment for insulin resistance (r=0.328, P=.003) in the T2DM group. In addition, 10-unit changes in SFRP1 levels showed the risk of T2DM in both the unadjusted (odds ratio [OR] [95% CI]=1.564 [1.359-1.800]) and adjusted models accounting for age, gender, and body mass index (OR [95% CI]=1.564 [1.361-1.799]; P<.001). A cut-off value of SFRP1 (105.83 pg/mL) was identified to distinguish between the T2DM patients and the healthy subjects, with sensitivity of 75.0% and specificity of 80.0%. According to our research, there was a significant and positive link between the amount of SFRP1 and the likelihood of developing T2DM as well as the related factors like insulin resistance index and TNF-α. These results indicated that SFRP1 might have a potential role in the development of T2DM.